Roivant Sciences Ltd.

SEC Form 4 insider trading activity

Roivant Sciences Ltd. has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Dec 12, 2025.

On the most recent filing, Roivant Sciences Ltd. is listed as Director, 10% Owner at Immunovant, Inc. Inside the rolling window, Roivant Sciences Ltd. reported 1 open-market purchase totaling $350.0M in IMVT and no open-market sales.

Companies traded

Other insiders at IMVT

Insider Buying

$350.0M

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
IMVTPurchase$350.0MDec 12SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Roivant Sciences Ltd. made?

Roivant Sciences Ltd. has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2025.

Which companies does Roivant Sciences Ltd. trade?

Roivant Sciences Ltd. has filed SEC Form 4 disclosures for 1 company, including IMVT.

When was Roivant Sciences Ltd.'s most recent SEC Form 4 filing?

Roivant Sciences Ltd.'s most recent SEC Form 4 filing on Tracefour is dated Dec 12, 2025.

What is Roivant Sciences Ltd.'s total buy and sell value in the current window?

Inside the rolling retention window, Roivant Sciences Ltd. bought $350.0M and sold $0 based on SEC Form 4 filings.

What was Roivant Sciences Ltd.'s largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 16,666,666 IMVT shares on 2025-12-12, worth $350.0M, per SEC Form 4 filings.